ATE243038T1 - Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend - Google Patents

Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend

Info

Publication number
ATE243038T1
ATE243038T1 AT00970752T AT00970752T ATE243038T1 AT E243038 T1 ATE243038 T1 AT E243038T1 AT 00970752 T AT00970752 T AT 00970752T AT 00970752 T AT00970752 T AT 00970752T AT E243038 T1 ATE243038 T1 AT E243038T1
Authority
AT
Austria
Prior art keywords
xanthang
fluorochinolone
antibiotic
gum
pharmaceutical compositions
Prior art date
Application number
AT00970752T
Other languages
English (en)
Inventor
Bhagwati P Kabra
Original Assignee
Alcon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Inc filed Critical Alcon Inc
Application granted granted Critical
Publication of ATE243038T1 publication Critical patent/ATE243038T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AT00970752T 1999-11-01 2000-10-10 Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend ATE243038T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16269399P 1999-11-01 1999-11-01
PCT/US2000/028031 WO2001032181A2 (en) 1999-11-01 2000-10-10 Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum

Publications (1)

Publication Number Publication Date
ATE243038T1 true ATE243038T1 (de) 2003-07-15

Family

ID=22586735

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00970752T ATE243038T1 (de) 1999-11-01 2000-10-10 Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend

Country Status (19)

Country Link
US (1) US6331540B1 (de)
EP (1) EP1225898B1 (de)
JP (1) JP2003513046A (de)
KR (1) KR20020048967A (de)
CN (1) CN1384745A (de)
AR (1) AR026227A1 (de)
AT (1) ATE243038T1 (de)
AU (1) AU8008300A (de)
BR (1) BR0015256A (de)
CA (1) CA2386822A1 (de)
DE (1) DE60003445T2 (de)
DK (1) DK1225898T3 (de)
ES (1) ES2199873T3 (de)
HK (1) HK1045940A1 (de)
MX (1) MXPA02004349A (de)
PL (1) PL354928A1 (de)
PT (1) PT1225898E (de)
TR (1) TR200201174T2 (de)
WO (1) WO2001032181A2 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050009922A1 (en) * 2001-01-27 2005-01-13 Carlson Paul E. Stable aqueous antimicrobial suspension
PT1567641E (pt) * 2001-08-24 2012-08-21 Uvic Industry Partnerships Inc Proaerolisina contendo sequência de activação de proteases e métodos de uso para o tratamento do cancro da próstata
ATE528003T1 (de) 2002-07-31 2011-10-15 Senju Pharma Co Wässrige, flüssigkeitszubereitungen und lichtstabilisierte wässrige flüssigkeitszubereitungen
US8877168B1 (en) 2002-07-31 2014-11-04 Senju Pharmaceuticals Co., Ltd. Aqueous liquid preparations and light-stabilized aqueous liquid preparations
US8524735B2 (en) 2005-05-18 2013-09-03 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
MX359219B (es) * 2005-05-18 2018-09-19 Raptor Pharmaceuticals Inc Fluoroquinolonas aerosolizadas y sus usos.
BRPI0719776A2 (pt) * 2006-10-12 2014-04-22 Kyorin Seiyaku Kk Preparação líquida aquosa tendo penetração de gatifloxacino intraocular melhorada
BRPI0909366A2 (pt) 2008-03-31 2017-06-13 Kyorin Seiyaku Kk preparação líquida aquosa contendo gatifloxacina
JP5535900B2 (ja) * 2008-03-31 2014-07-02 杏林製薬株式会社 ガチフロキサシン含有水性液剤、その製造方法、および、該水性液剤の低温保存および凍結融解時の沈殿生成を抑制する方法
TWI544934B (zh) * 2008-06-09 2016-08-11 愛爾康研究有限公司 含有氟喹諾酮抗生素藥物之經改良藥學組成物
CA2739897C (en) 2008-10-07 2017-10-03 Mpex Pharmaceuticals, Inc. Aerosol fluoroquinolone formulations for improved pharmacokinetics
CA2739893C (en) 2008-10-07 2016-10-04 Mpex Pharmaceuticals, Inc. Inhalation of levofloxacin for reducing lung inflammation
SI2473170T1 (sl) 2009-09-04 2019-10-30 Horizon Orphan Llc Uporaba aerosoliziranega levofloksacina za zdravljenje cistične fibroze
JP5306537B2 (ja) * 2010-02-24 2013-10-02 森永乳業株式会社 昆布抽出物を有効成分とする抗菌補助剤、抗菌組成物、及び飲食品
US9050357B2 (en) * 2010-03-08 2015-06-09 Cp Kelco U.S., Inc. Compositions and methods for producing consumables for patients with dysphagia
GR1008168B (el) 2013-03-14 2014-04-08 "Φαρματεν Α.Β.Ε.Ε.", Παρεντερικο σκευασμα αντιβακτηριακου παραγοντα φθοριοκινολονης και μεθοδος για την παρασκευη αυτου
JP6602534B2 (ja) * 2013-09-27 2019-11-06 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6538322B2 (ja) * 2013-09-27 2019-07-03 三栄源エフ・エフ・アイ株式会社 液状とろみ剤
JP6713728B2 (ja) * 2015-05-01 2020-06-24 三栄源エフ・エフ・アイ株式会社 液状増粘剤
IL311727A (en) 2017-07-07 2024-05-01 Epicentrx Inc Preparations for intravenous administration of medical substances
US12016855B2 (en) 2020-08-26 2024-06-25 Somerset Therapeutics, Llc Prednisolone and moxifloxacin compositions and methods
US11298315B2 (en) 2020-08-26 2022-04-12 Somerset Therapeutics, Llc. Triamcinolone and moxifloxacin compositions
US12102632B2 (en) 2020-08-26 2024-10-01 Somerset Therapeutics, Llc Quinolone dispersions
US11510930B2 (en) 2020-08-26 2022-11-29 Somerset Therapeutics, Llc Gatifloxacin, prednisolone, and bromfenac compositions and methods

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3944427A (en) 1970-04-06 1976-03-16 Itek Corporation Gelable and gelled compositions
US3700451A (en) 1970-04-06 1972-10-24 Itek Corp Gelable and gelled compositions
US3784712A (en) 1970-12-23 1974-01-08 Gen Foods Corp Gum gelling system xanthan-tara dessert gel
CA1070629A (en) 1975-11-10 1980-01-29 Allen I. Laskin Process for modifying biopolymers
US4135979A (en) 1976-08-24 1979-01-23 Merck & Co., Inc. Treatment of xanthan gum to improve clarity
US4136178A (en) 1977-01-31 1979-01-23 American Home Products Corp. Locust bean gum therapeutic compositions
US4136177A (en) 1977-01-31 1979-01-23 American Home Products Corp. Xanthan gum therapeutic compositions
US4136173A (en) 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
GB8318403D0 (en) 1983-07-07 1983-08-10 Sutherland I W Gel-forming polysaccharides
FR2551087B1 (fr) 1983-08-30 1986-03-21 Rhone Poulenc Spec Chim Procede de traitement d'une solution de polysaccharide et son utilisation
DE3335593A1 (de) 1983-09-30 1985-04-11 Diamalt AG, 8000 München Gelier- und verdickungsmittel auf der basis von cassia-galactomannanen
US4717713A (en) 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
US4708861A (en) 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
FR2588189B1 (fr) 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
US4647470A (en) 1985-11-27 1987-03-03 Merck & Co., Inc. Low-acetyl gellan gum blends
FR2618333B1 (fr) 1987-07-20 1990-07-13 Merck Sharp & Dohme Composition pharmaceutique et/ou cosmetique a usage topique contenant de la gomme rhamsam
US5192535A (en) 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US4814160A (en) 1988-03-01 1989-03-21 Colgate-Palmolive Company Non-bleeding striped dentifrice
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5234957A (en) 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
DE3843416A1 (de) 1988-12-23 1990-06-28 Wolff Walsrode Ag Xanthan mit verbesserter loeslichkeit und verfahren zur herstellung
CA2021414C (en) 1989-07-25 2004-09-28 Daniel H. Doherty Genetic control of acetylation and pyruvylation of xanthan gum
US5461081A (en) 1989-09-28 1995-10-24 Alcon Laboratories, Inc. Topical ophthalmic pharmaceutical vehicles
FR2653021A1 (fr) 1989-10-17 1991-04-19 Merck Sharp & Dohme Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.
JP2594486B2 (ja) 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
US5212162A (en) 1991-03-27 1993-05-18 Alcon Laboratories, Inc. Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions
AU2672892A (en) 1991-09-17 1993-04-27 Alcon Laboratories, Inc. Compositions containing quinolone antibiotics and sulfonate of polystyrol
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
US5318780A (en) 1991-10-30 1994-06-07 Mediventures Inc. Medical uses of in situ formed gels
US5473062A (en) 1992-10-29 1995-12-05 Takeda Chemical Industries, Ltd. Process for producing purified xanthan gum
JP3228315B2 (ja) 1993-04-23 2001-11-12 信越化学工業株式会社 キサンタンガムの汚染生菌数を減少させる方法
ES2068762B1 (es) * 1993-07-21 1995-12-01 Lipotec Sa Un nuevo preparado farmaceutico para mejorar la biodisponibilidad de drogas de dificil absorcion y procedimiento para su obtencion.
EP0757555A4 (de) 1994-01-14 1999-04-07 Lee Shahinian Jr Verfahren für langanhaltende und erweiterte hornhautanalgesie
US5422116A (en) 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
DK0754032T3 (da) 1994-04-08 2002-04-02 Atrix Lab Inc Flydende frigivelsessammensætninger
US5523301A (en) 1994-08-05 1996-06-04 Merck & Co., Inc. Optic nerve health
DK0725628T3 (da) 1994-08-30 2001-12-27 Alcon Lab Inc Termisk geldannende lægemiddelindgivelsesvehikler indeholdende celluloseethere
US5972326A (en) 1995-04-18 1999-10-26 Galin; Miles A. Controlled release of pharmaceuticals in the anterior chamber of the eye
FR2742336B1 (fr) 1995-12-19 1998-03-06 Chauvin Lab Sa Collyre destine notamment au traitement de l'oeil sec
SE9603480L (sv) 1996-09-23 1998-03-24 Johan Carlfors Beredningsform för svårlösliga läkemedel
FR2754712B1 (fr) 1996-10-17 1999-09-03 Merck Sharp Dohme Chibret Lab Compositions ophtalmiques
US5888493A (en) 1996-12-05 1999-03-30 Sawaya; Assad S. Ophthalmic aqueous gel formulation and related methods
WO1998053809A1 (en) 1997-05-30 1998-12-03 Merck & Co., Inc. Ophthalmic compositions for treating ocular hypertension
WO1999000133A1 (en) 1997-06-26 1999-01-07 Merck & Co., Inc. Method for optimizing retinal and optic nerve health
CA2302561C (en) * 1997-09-12 2006-02-14 The Procter & Gamble Company Cleansing and conditioning article for skin or hair
NZ506921A (en) 1998-04-07 2002-02-01 Alcon Lab Inc Gelling ophthalmic compositions containing xanthan gum
US6166012A (en) * 1999-07-30 2000-12-26 Allergan Sales, Inc. Antibiotic compositions and method for using same

Also Published As

Publication number Publication date
PL354928A1 (en) 2004-03-22
PT1225898E (pt) 2003-10-31
AU8008300A (en) 2001-05-14
BR0015256A (pt) 2002-06-18
WO2001032181A3 (en) 2002-05-02
JP2003513046A (ja) 2003-04-08
EP1225898A2 (de) 2002-07-31
ES2199873T3 (es) 2004-03-01
EP1225898B1 (de) 2003-06-18
HK1045940A1 (zh) 2002-12-20
CN1384745A (zh) 2002-12-11
AR026227A1 (es) 2003-01-29
MXPA02004349A (es) 2003-09-22
CA2386822A1 (en) 2001-05-10
US6331540B1 (en) 2001-12-18
TR200201174T2 (tr) 2002-08-21
WO2001032181A2 (en) 2001-05-10
DK1225898T3 (da) 2003-09-15
DE60003445D1 (de) 2003-07-24
DE60003445T2 (de) 2003-12-24
KR20020048967A (ko) 2002-06-24

Similar Documents

Publication Publication Date Title
ATE243038T1 (de) Pharmazeutische zusammensetzungen ein fluorchinolonantibiotikum und xanthangummi enthaltend
EE04904B1 (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ATE284223T1 (de) Zusammensetzung enthaltend ein tramadol und ein antikonvulsives arzneimittel
DE69940904D1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
ATE331529T1 (de) Antigen enthaltende pharmazeutische zusammensetzung
IL145177A0 (en) A pharmaceutical composition containing xenon
NO20015175D0 (no) Farmasöytisk sammensetning
DE69822172D1 (de) Levosimendanhaltige oral anzuwendende arzneizusammensetzungen
ATE402691T1 (de) Pharmazeutische zusammensetzungen zur oralen und topischen verabreichung
ATE383868T1 (de) Pharmazeutische formulierung enthaltend megalatran und dessen pro-pharmaka
ITMI982222A0 (it) Composizioni farmaceutiche orali contenenti buprenorfina
DE69807768D1 (de) Rapamycin enthaltende Formulierungen zur oralen Verabreichung
HUP0201116A2 (en) Erythromycin derivatives and pharmaceutical compositions containing them and their use
EE9900545A (et) Farmatseutiline kompositsioon
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
ATE228839T1 (de) Tizoxanide und nitazoxanide enthaltende pharmazeutische zusammensetzungen
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69827947T2 (de) Rapamycin-formulierungen zur oralen verabreichung
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
FI4488U1 (fi) Farmaseuttinen koostumus
EP1124557A4 (de) Pharmazeutische zusammensetzung
HUP0201443A3 (en) 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives and pharmaceutical compositions containing them
ATE279927T1 (de) Pharmazeutische zusammensetzungen enthaltend tobramycin und xanthangummi

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1225898

Country of ref document: EP